Magazine Article | August 1, 2022

The Insurance Implications Of Global Clinical Trials

Source: Life Science Leader

By Lee Farrow

The COVID-19 pandemic underscored the importance of global clinical trials as the life sciences industry sprinted toward a vaccine for the virus. While the speed and efficacy of such lifesaving work were thrust into a sudden spotlight, the clinical trial space has been progressing rapidly for many years.

Global clinical trials have grown tremendously over the past two decades, in total number and in complexity. In 2000, 2,119 clinical trials were registered with ClinicalTrials.gov. In the years since, the volume of trials has increased dramatically — 37,027 trials were registered in 2021 alone. As the market expands on an international scale, so, too, must the risk-management capabilities of the firms conducting these trials.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader